Back to School: How biopharma can reboot drug development. Access exclusive analysis here

PharmaNetics, Duke University Medical Center deal

PHAR will provide for two years point-of-care diagnostics

Read the full 80 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE